Resveratrol in the chemoprevention and chemotherapy of breast cancer

Phytopharmaceuticals in Cancer Chemoprevention

Volumn , Issue , 2004, Pages 449-464

  Tangkeangsirisin, Wisit ^a,b   Serrero, Ginette ^a,b  

^a A&G Pharmaceutical   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77958188329     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (139)

1. Kris-Etherton, P.M., Hecker, K.D., Bonanome, A., Coval, S.M., Binkoski, A.E., Hilpert,. F., Griel, A.E., and Etherton, T.D., Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer, Am. J. Med., 113 (Suppl. 9B), 71S-88S, 2002.
2. Burns, J., Yokota, T., Ashihara, H., Lean, M.E., and Crozier, A., Plant foods and herbal sources of resveratrol, J. Agric. Food Chem., 50 (11), 3337-3340, 2002.
3. Constant, J., Alcohol, ischemic heart disease, and the French paradox, Coron. Artery Dis., 8 (10), 645-649, 1997.
4. Kimura, Y., Okuda, H., and Arichi, S., Effects of stilbenes on arachidonate metabolism in leukocytes, Biochim. Biophys. Acta, 834 (2), 275-278, 1985.
5. Basly, J.P., Marre-Fournier, F., Le Bail, J.C., Habrioux, G., and Chulia, A.J., Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol, Life Sci., 66 (9), 769-777, 2000.
6. Waffo-Teguo, P., Hawthorne, M.E., Cuendet, M., Merillon, J.M., Kinghorn, A.D., Pezzuto, J.M., and Mehta, R.G., Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures, Nutr. Cancer, 40 (2), 173-179, 2001.
7. Waffo-Teguo, P., Lee, D., Cuendet, M., Merillon, J., Pezzuto, J.M., and Kinghorn, A.D., Two new stilbene dimer glucosides from grape (Vitis vinifera) cell cultures, J. Nat. Prod., 64 (1), 136-138, 2001.
8. Waffo Teguo, P., Fauconneau, B., Deffieux, G., Huguet, F., Vercauteren, J., and Merillon, J.M., Isolation, identification, and antioxidant activity of three stilbene glucosides newly extracted from Vitis vinifera cell cultures, J. Nat. Prod., 61 (5), 655-657, 1998.
9. Soleas, G.J., Diamandis, E.P., and Goldberg, D.M., Resveratrol: a molecule whose time has come? And gone?, Clin. Biochem., 30 (2), 91-113, 1997.
10. Romero-Perez, A.I., Lamuela-Raventos, R.M., Andres-Lacueva, C., and de La Torre-Boronat, M.C., Method for the quantitative extraction of resveratrol and piceid isomers in grape berry skins: effect of powdery mildew on the stilbene content, J. Agric. Food Chem., 49 (1), 210-215, 2001.
11. Wang, Y., Catana, F., Yang, Y., Roderick, R., and van Breemen, R.B., An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine, J. Agric. Food Chem., 50 (3), 431-435, 2002.
12. Goldberg, D.M., Yan, J., and Soleas, G.J., Absorption of three wine-related polyphenols in three different matrices by healthy subjects, Clin. Biochem., 36 (1), 79-87, 2003.
13. Bhat, K.P. and Pezzuto, J.M., Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells, Cancer Res., 61 (16), 6137-6144, 2001.
14. el-Mowafy, A.M., Abou-Zeid, L.A., and Edafiogho, I., Recognition of resveratrol by the human estrogen receptor-alpha: a molecular modeling approach to understand its biological actions, Med. Princ. Pract., 11 (2), 86-92, 2002.
15. Gehm, B.D., McAndrews, J.M., Chien, P.Y., and Jameson, J.L., Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor, Proc. Natl. Acad. Sci., USA, 94 (25), 14138-14143, 1997.
16. Levenson, A.S., Gehm, B.D., Pearce, S.T., Horiguchi, J., Simons, L.A., Ward, III J.E., Jameson, J.L., and Jordan, V.C., Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha, Int. J. Cancer, 104 (5), 587-596, 2003.
17. Lu, R. and Serrero, G., Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells, J. Cell. Physiol., 179 (3), 297-304, 1999.
18. Serrero, G. and Lu, R., Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells, Antioxid. Redox Signal, 3 (6), 969-979, 2001.
19. Bowers, J.L., Tyulmenkov, V.V., Jernigan, S.C., and Klinge, C.M., Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta, Endocrinology, 141 (10), 3657-3667, 2000.
20. Morito, K., Hirose, T., Kinjo, J., Hirakawa, T., Okawa, M., Nohara, T., Ogawa, S., Inoue, S., Muramatsu, M., and Masamune, Y., Interaction of phytoestrogens with estrogen receptors alpha and beta, Biol. Pharm. Bull., 24 (4), 351-356, 2001.
21. Schmitt, E., Lehmann, L., Metzler, M., and Stopper, H., Hormonal and genotoxic activity of resveratrol, Toxicol. Lett., 136 (2), 133-142, 2002.
22. Klinge, C.M., Estrogen receptor interaction with estrogen response elements, Nucleic Acids Res., 29 (14), 2905-2919, 2001.
23. Bhat, K.P., Lantvit, D., Christov, K., Mehta, R.G., Moon, R.C., and Pezzuto, J.M., Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models, Cancer Res., 61 (20), 7456-7463, 2001.
24. Yoon, K., Pallaroni, L., Stoner, M., Gaido, K., and Safe, S., Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements, J. Steroid Biochem. Mol. Biol., 78 (1), 25-32, 2001.
25. Bove, K., Lincoln, D.W., and Tsan, M.F., Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo, Biochem. Biophys. Res. Commun., 291 (4), 1001-1005, 2002.
26. Damianaki, A., Bakogeorgou, E., Kampa, M., Notas, G., Hatzoglou, A., Panagiotou, S., Gemetzi, C., Kouroumalis, E., Martin, P.M., and Castanas, E., Potent inhibitory action of red wine polyphenols on human breast cancer cells, J. Cell. Biochem., 78 (3), 429-441, 2000.
27. Hsieh, T.C., Burfeind, P., Laud, K., Backer, J.M., Traganos, F., Darzynkiewicz, Z., and Wu, J.M., Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials, Int. J. Oncol., 15 (2), 245-252, 1999.
28. Mgbonyebi, O.P., Russo, J., and Russo, I.H., Antiproliferative effect of synthetic resveratrol on human breast epithelial cells, Int. J. Oncol., 12 (4), 865-869, 1998.
29. Nakagawa, H., Kiyozuka, Y., Uemura, Y., Senzaki, H., Shikata, N., Hioki, K., and Tsubura, A., Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator, J. Cancer Res. Clin. Oncol., 127 (4), 258-264, 2001.
30. Pozo-Guisado, E., Alvarez-Barrientos, A., Mulero-Navarro, S., Santiago-Josefat, B., and Fernandez-Salguero, P.M., The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle, Biochem. Pharmacol., 64 (9), 1375-1386, 2002.
31. Prall, O.W., Sarcevic, B., Musgrove, E.A., Watts, C.K., and Sutherland, R.L., Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2, J. Biol. Chem., 272 (16), 10882-10894, 1997.
32. Ahmad, N., Adhami, V.M., Afaq, F., Feyes, D.K., and Mukhtar, H., Resveratrol causes WAF-1/p21- mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells, Clin. Cancer Res., 7 (5), 1466-1473, 2001.
33. Kuo, P.L., Chiang, L.C., and Lin, C.C., Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells, Life Sci., 72 (1), 23-34, 2002.
34. Mitchell, S.H., Zhu, W., and Young, C.Y., Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells, Cancer Res., 59 (23), 5892-5895, 1999.
35. Rodrigue, C.M., Arous, N., Bachir, D., Smith-Ravin, J., Romeo, P.H., Galacteros, F., and Garel, M.C., Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation, Br. J. Haematol., 113 (2), 500-507, 2001.
36. Huang, C., Ma, W.Y., Goranson, A., and Dong, Z., Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway, Carcinogenesis, 20 (2), 237-242, 1999.
37. Lin, H.Y., Shih, A., Davis, F.B., Tang, H.Y., Martino, L.J., Bennett, J.A., and Davis, P.J., Resveratrolinduced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line, J. Urol., 168 (2), 748-755, 2002.
38. She, Q.B., Bode, A.M., Ma, W.Y., Chen, N.Y., and Dong, Z., Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase, Cancer Res., 61 (4), 1604-1610, 2001.
39. Shih, A., Lin, H.Y., Davis, F.B., and Davis, P.J., Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase, Biochemistry, 40 (9), 2870-2878, 2001.
40. Mahyar-Roemer, M., Katsen, A., Mestres, P., and Roemer, K., Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse, Int. J. Cancer, 94 (5), 615-622, 2001.
41. Soleas, G.J., Goldberg, D.M., Grass, L., Levesque, M., and Diamandis, E.P., Do wine polyphenols modulate p53 gene expression in human cancer cell lines?, Clin. Biochem., 34 (5), 415-420, 2001.
42. Yee, D., The insulin-like growth factors and breast cancer ?*? revisited, Breast Cancer Res. Treat., 47 (3), 197-199, 1998.
43. Dickson, R.B. and Lippman, M.E., Growth factors in breast cancer, Endocr. Rev., 16 (5), 559-589, 1995.
44. Dickson, R.B., Thompson, E.W., and Lippman, M.E., Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids, J. Steroid Biochem. Mol. Biol., 37 (3), 305-316, 1990.
45. Stewart, A.J., Johnson, M.D., May, F.E., and Westley, B.R., Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells, J. Biol. Chem., 265 (34), 21172-21178, 1990.
46. Lu, R. and Serrero, G., Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468, Proc. Natl. Acad. Sci. USA, 97 (8), 3993-3998, 2000.
47. Lu, R. and Serrero, G., Stimulation of PC cell-derived growth factor (epithelin/granulin precursor) expression by estradiol in human breast cancer cells, Biochem. Biophys. Res. Commun., 256 (1), 204-207, 1999.
48. Arteaga, C.L. and Moses, H.L., TGF-beta in mammary development and neoplasia, J. Mammary Gland Biol. Neoplasia, 1 (4), 327-329, 1996.
49. Jeng, M.H., ten Dijke, P., Iwata, K.K., and Jordan, V.C., Regulation of the levels of three transforming growth factor beta mRNAs by estrogen and their effects on the proliferation of human breast cancer cells, Mol. Cell. Endocrinol., 97 (1-2), 4, 1993.
50. Knabbe, C., Lippman, M.E., Wakefield, L.M., Flanders, K.C., Kasid, A., Derynck, R., and Dickson, R.B., Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells, Cell, 48 (3), 417-428, 1987.
51. Paik, J., Blaner, W.S., Sommer, K.M., Moe, R., and Swisshlem, K., Retinoids, retinoic acid receptors, and breast cancer, Cancer Invest., 21 (2), 304-312, 2003.
52. Grunberg, E., Eckert, K., Karsten, U., and Maurer, H.R., Effects of differentiation inducers on cell phenotypes of cultured nontransformed and immortalized mammary epithelial cells: a comparative immunocytochemical analysis, Tumour Biol., 21 (4), 211-223, 2000.
53. Lazzaro, G., Agadir, A., Qing, W., Poria, M., Mehta, R.R., Moriarty, R.M., Das Gupta, T.K., Zhang, X.K., and Mehta, R.G., Induction of differentiation by 1alpha-hydroxyvitamin D(5) in T47D human breast cancer cells and its interaction with vitamin D receptors, Eur. J. Cancer, 36 (6), 780-786, 2000.
54. Lamartiniere, C.A., Cotroneo, M.S., Fritz, W.A., Wang, J., Mentor-Marcel, R., and Elgavish, A., Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate, J. Nutr., 132 (3), 552S-558S, 2002.
55. Cotroneo, M.S., Wang, J., Fritz, W.A., Eltoum, I.E., and Lamartiniere, C.A., Genistein action in the prepubertal mammary gland in a chemoprevention model, Carcinogenesis, 23 (9), 1467-1474, 2002.
56. Asou, H., Koshizuka, K., Kyo, T., Takata, N., Kamada, N., and Koeffier, H.P., Resveratrol, a natural product derived from grapes, is a new inducer of differentiation in human myeloid leukemias, Int. J. Hematol., 75 (5), 528-533, 2002.
57. Jang, M. and Pezzuto, J.M., Cancer chemopreventive activity of resveratrol, Drugs Exp. Clin. Res., 25 (2-3), 4, 1999.
58. Ragione, F.D., Cucciolla, V., Borriello, A., Pietra, V.D., Racioppi, L., Soldati, G., Manna, C., Galletti, P., and Zappia, V., Resveratrol arrests the cell division cycle at S/G2 phase transition, Biochem. Biophys. Res. Commun., 250 (1), 53-58, 1998.
59. Wolter, F. and Stein, J., Resveratrol enhances the differentiation induced by butyrate in caco-2 colon cancer cells, J. Nutr., 132 (7), 2082-2086, 2002.
60. Melzig, M.F. and Escher, F., Induction of neutral endopeptidase and angiotensin-converting enzyme activity of SK-N-SH cells in vitro by quercetin and resveratrol, Pharmazie, 57 (8), 556-558, 2002.
61. Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W., Fong, H.H., Farnsworth, N.R., Kinghorn, A.D., Mehta, R.G., Moon, R.C., and Pezzuto, J.M., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science, 275 (5297), 218-220, 1997.
62. Kiefer, W. and Dannhardt, G., COX-2 inhibition and the control of pain, Curr. Opin. Investig. Drugs, 3 (9), 1348-1358, 2002.
63. Karim, M.M., Hayashi, Y., Inoue, M., Imai, Y., Ito, H., and Yamamoto, M., Cox-2 expression in retinoblastoma, Am. J. Ophthalmol., 129 (3), 398-401, 2000.
64. Shono, T., Tofilon, P.J., Bruner, J.M., Owolabi, O., and Lang, F.F., Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations, Cancer Res., 61 (11), 4375-4381, 2001.
65. Wardlaw, S.A., March, T.H., and Belinsky, S.A., Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions, Carcinogenesis, 21 (7), 1371-1377, 2000.
66. Schlosser, W., Schlosser, S., Ramadani, M., Gansauge, F., Gansauge, S., and Beger, H.G., Cyclooxygenase-2 is overexpressed in chronic pancreatitis, Pancreas, 25 (1), 26-30, 2002.
67. Tomozawa, S., Tsuno, N.H., Sunami, E., Hatano, K., Kitayama, J., Osada, T., Saito, S., Tsuruo, T., Shibata, Y., and Nagawa, H., Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer, Br. J. Cancer, 83 (3), 324-328, 2000.
68. Khuri, F.R., Wu, H., Lee, J.J., Kemp, B.L., Lotan, R., Lippman, S.M., Feng, L., Hong, W.K., and Xu, X.C., Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer, Clin. Cancer Res., 7 (4), 861-867, 2001.
69. Kagoura, M., Toyoda, M., Matsui, C., and Morohashi, M., Immunohistochemical expression of cyclooxygenase-2 in skin cancers, J. Cutan. Pathol., 28 (6), 298-302, 2001.
70. Hosomi, Y., Yokose, T., Hirose, Y., Nakajima, R., Nagai, K., Nishiwaki, Y., and Ochiai, A., Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung, Lung Cancer, 30 (2), 73-81, 2000.
71. Zhang, H. and Sun, X.F., Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer, Am. J. Gastroenterol., 97 (4), 1037-1041, 2002.
72. Jacoby, R.F., Seibert, K., Cole, C.E., Kelloff, G., and Lubet, R.A., The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis, Cancer Res., 60 (18), 5040-5044, 2000.
73. Oshima, M., Murai, N., Kargman, S., Arguello, M., Luk, P., Kwong, E., Taketo, M.M., and Evans, J.F., Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor, Cancer Res., 61 (4), 1733-1740, 2001.
74. Subbaramaiah, K., Chung, W.J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J.M., and Dannenberg, A.J., Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells, J. Biol. Chem., 273 (34), 21875-21882, 1998.
75. Martinez, J. and Moreno, J.J., Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production, Biochem. Pharmacol., 59 (7), 865-870, 2000.
76. Liehr, J.G. and Roy, D., Free radical generation by redox cycling of estrogens, Free Radic. Biol. Med., 8 (4), 415-423, 1990.
77. Liehr, J.G. and Ricci, M.J., 4-Hydroxylation of estrogens as marker of human mammary tumors, Proc. Natl. Acad. Sci. USA, 93 (8), 3294-3296, 1996.
78. Chang, T.K., Lee, W.B., and Ko, H.H., trans-Resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1, Can. J. Physiol. Pharmacol., 78 (11), 874-881, 2000.
79. Ciolino, H.P. and Yeh, G.C., Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol, Mol. Pharmacol., 56 (4), 760-767, 1999.
80. Huynh, H.T. and Teel, R.W., Effects of plant-derived phenols on rat liver cytochrome P450 2B1 activity, Anticancer Res., 22 (3), 1699-1703, 2002.
81. Mikstacka, R., Gnojkowski, J., and Baer-Dubowska, W., Effect of natural phenols on the catalytic activity of cytochrome P450 2E1, Acta Biochim. Pol., 49 (4), 917-925, 2002.
82. Sharma, S., Stutzman, J.D., Kelloff, G.J., and Steele, V.E., Screening of potential chemopreventive agents using biochemical markers of carcinogenesis, Cancer Res., 54 (22), 5848-5855, 1994.
83. Shamon, L.A., Chen, C., Mehta, R.G., Steele, V., Moon, R.C., and Pezzuto, J.M., A correlative approach for the identification of antimutagens that demonstrate chemopreventive activity, Anticancer Res., 14 (5A), 1775-1778, 1994.
84. Fauconneau, B., Waffo-Teguo, P., Huguet, F., Barrier, L., Decendit, A., and Merillon, J.M., Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests, Life Sci., 61 (21), 2103-2110, 1997.
85. Henry, L.A. and Witt, D.M., Resveratrol: phytoestrogen effects on reproductive physiology and behavior in female rats, Horm. Behav., 41 (2), 220-228, 2002.
86. Turner, R.T., Evans, G.L., Zhang, M., Maran, A., and Sibonga, J.D., Is resveratrol an estrogen agonist in growing rats?, Endocrinology, 140 (1), 50-54, 1999.
87. Yu, C., Shin, Y.G., Chow, A., Li, Y., Kosmeder, J.W., Lee, Y.S., Hirschelman, W.H., Pezzuto, J.M., Mehta, R.G., and van Breemen, R.B., Human, rat, and mouse metabolism of resveratrol, Pharm. Res., 19 (12), 1907-1914, 2002.
88. Day, A.J., DuPont, M.S., Ridley, S., Rhodes, M., Rhodes, M.J., Morgan, M.R., and Williamson, G., Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver betaglucosidase activity, FEBS Lett., 436 (1), 71-75, 1998.
89. Solomon, C.G. and Dluhy, R.G., Rethinking postmenopausal hormone therapy, New England J. Med., 348 (7), 579-580, 2003.
90. Mizutani, K., Ikeda, K., Kawai, Y., and Yamori, Y., Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells, Biochem. Biophys. Res. Commun., 253 (3), 859-863, 1998.
91. Hung, L.M., Chen, J.K., Huang, S.S., Lee, R.S., and Su, M.J., Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes, Cardiovasc. Res., 47 (3), 549-555, 2000.
92. Sato, M., Maulik, G., Bagchi, D., and Das, D.K., Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin, Free Radic. Res., 32 (2), 135-144, 2000.
93. Bagchi, D., Das, D.K., Tosaki, A., Bagchi, M., and Kothari, S.C., Benefits of resveratrol in women’s health, Drugs Exp. Clin. Res., 27 (5-6), 4, 2001.
94. Mizutani, K., Ikeda, K., Kawai, Y., and Yamori, Y., Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats, Clin. Exp. Pharmacol. Physiol., 28 (1-2), 4, 2001.
95. Fitzpatrick, D.F., Hirschfield, S.L., and Coffey, R.G., Endothelium-dependent vasorelaxing activity of wine and other grape products, Am. J. Physiol., 265 (2, Pt. 2), H774-778, 1993.
96. Chen, C.K. and Pace-Asciak, C.R., Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta, Gen. Pharmacol., 27 (2), 363-366, 1996.
97. Bastianetto, S. and Quirion, R., Natural extracts as possible protective agents of brain aging, Neurobiol. Aging, 23 (5), 891-897, 2002.
98. Soleas, G.J., Grass, L., Josephy, P.D., Goldberg, D.M., and Diamandis, E.P., A comparison of the anticarcinogenic properties of four red wine polyphenols, Clin. Biochem., 35 (2), 119-14, 2002.
99. Olas, B., Zbikowska, H.M., Wachowicz, B., Krajewski, T., Buczynski, A., and Magnuszewska, A., Inhibitory effect of resveratrol on free radical generation in blood platelets, Acta Biochim. Pol., 46 (4), 961-966, 1999.
100. Olas, B., Wachowicz, B., Szewczuk, J., Saluk-Juszczak, J., and Kaca, W., The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin, Microbios, 105 (410), 7-13, 2001.
101. Orsini, F., Pelizzoni, F., Verotta, L., Aburjai, T., and Rogers, C.B., Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-beta-D-glucopyranoside and related compounds, J. Nat. Prod., 60 (11), 1082-1087, 1997.
102. Dobrydneva, Y., Williams, R.L., and Blackmore, P.F., trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets, Br. J. Pharmacol., 128 (1), 149-157, 1999.
103. Pace-Asciak, C.R., Rounova, O., Hahn, S.E., Diamandis, E.P., and Goldberg, D.M., Wines and grape juices as modulators of platelet aggregation in healthy human subjects, Clin. Chim. Acta, 246 (1-2), 4, 1996.
104. Park, J.W., Choi, Y.J., Jang, M.A., Lee, Y.S., Jun, D.Y., Suh, S.I., Baek, W.K., Suh, M.H., Jin, I.N., and Kwon, T.K., Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells, Cancer Lett., 163 (1), 43-49., 2001.
105. Orallo, F., Alvarez, E., Camina, M., Leiro, J.M., Gomez, E., and Fernandez, P., The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption, Mol. Pharmacol., 61 (2), 294-302, 2002.
106. Hung, L.M., Su, M.J., Chu, W.K., Chiao, C.W., Chan, W.F., and Chen, J.K., The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy, Br. J. Pharmacol., 135 (7), 1627-1633, 2002.
107. Imamura, G., Bertelli, A.A., Bertelli, A., Otani, H., Maulik, N., and Das, D.K., Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice, Am. J. Physiol. Heart Circ. Physiol., 282 (6), H1996-2003, 2002.
108. Wu, J.M., Wang, Z.R., Hsieh, T.C., Bruder, J.L., Zou, J.G., and Huang, Y.Z., Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (review), Int. J. Mol. Med., 8 (1), 3-17, 2001.
109. Zou, J.G., Wang, Z.R., Huang, Y.Z., Cao, K.J., and Wu, J.M., Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits, Int. J. Mol. Med., 11 (3), 317-320, 2003.
110. Moreno, J.J., Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth, J. Pharmacol. Exp. Ther., 294 (1), 333-338, 2000.
111. MacCarrone, M., Lorenzon, T., Guerrieri, P., and Agro, A.F., Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity, Eur. J. Biochem., 265 (1), 27-34, 1999.
112. Brakenhielm, E., Cao, R., and Cao, Y., Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes, FASEB J., 15 (10), 1798-1800, 2001.
113. Cao, Y., Cao, R., and Brakenhielm, E., Antiangiogenic mechanisms of diet-derived polyphenols, J. Nutr. Biochem., 13 (7), 380-390, 2002.
114. Igura, K., Ohta, T., Kuroda, Y., and Kaji, K., Resveratrol and quercetin inhibit angiogenesis in vitro, Cancer Lett., 171 (1), 11-16, 2001.
115. Kimura, Y. and Okuda, H., Effects of naturally occurring stilbene glucosides from medicinal plants and wine on tumour growth and lung metastasis in Lewis lung carcinoma-bearing mice, J. Pharm. Pharmacol., 52 (10), 1287-1295, 2000.
116. Atten, M.J., Attar, B.M., Milson, T., and Holian, O., Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism, Biochem. Pharmacol., 62 (10), 1423-1432, 2001.
117. Garcia-Garcia, J., Micol, V., de Godos, A., and Gomez-Fernandez, J.C., The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity, Arch. Biochem. Biophys., 372 (2), 382-388, 1999.
118. Fremont, L., Belguendouz, L., and Delpal, S., Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids, Life Sci., 64 (26), 2511-2521, 1999.
119. Stewart, J.R., Ward, N.E., Ioannides, C.G., and O’Brian, C.A., Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism, Biochemistry, 38 (40), 13244-13251, 1999.
120. Karlsson, J., Emgard, M., Brundin, P., and Burkitt, M.J., trans-Resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism, J. Neurochem., 75 (1), 141-150, 2000.
121. Wang, M., Jin, Y., and Ho, C.T., Evaluation of resveratrol derivatives as potential antioxidants and identification of a reaction product of resveratrol and 2, 2-diphenyl-1-picryhydrazyl radical, J. Agric. Food Chem., 47 (10), 3974-3977, 1999.
122. Ashby, J., Tinwell, H., Pennie, W., Brooks, A.N., Lefevre, P.A., Beresford, N., and Sumpter, J.P., Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects, J. Appl. Toxicol., 19 (1), 39-45, 1999.
123. Gao, X., Xu, Y.X., Janakiraman, N., Chapman, R.A., and Gautam, S.C., Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production, Biochem. Pharmacol., 62 (9), 1299-1308, 2001.
124. Chan, M.M., Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin, Biochem. Pharmacol., 63 (2), 99-104, 2002.
125. Daroch, F., Hoeneisen, M., Gonzalez, C.L., Kawaguchi, F., Salgado, F., Solar, H., and Garcia, A., In vitro antibacterial activity of Chilean red wines against Helicobacter pylori, Microbios, 104 (408), 79-85, 2001.
126. Matsuda, H., Kageura, T., Morikawa, T., Toguchida, I., Harima, S., and Yoshikawa, M., Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages, Bioorg. Med. Chem. Lett., 10 (4), 323-327, 2000.
127. Tsai, S.H., Lin-Shiau, S.Y., and Lin, J.K., Suppression of nitric oxide synthase and the downregulation of the activation of NFkappaB in macrophages by resveratrol, Br. J. Pharmacol., 126 (3), 673-680, 1999.
128. Palmieri, L., Mameli, M., and Ronca, G., Effect of resveratrol and some other natural compounds on tyrosine kinase activity and on cytolysis, Drugs Exp. Clin. Res., 25 (2-3), 4, 1999.
129. Jayatilake, G.S., Jayasuriya, H., Lee, E.S., Koonchanok, N.M., Geahlen, R.L., Ashendel, C.L., McLaughlin, J.L., and Chang, C.J., Kinase inhibitors from Polygonum cuspidatum, J. Nat. Prod., 56 (10), 1805-1810, 1993.
130. Uenobe, F., Nakamura, S., and Miyazawa, M., Antimutagenic effect of resveratrol against Trp-P-1, Mutat. Res., 373 (2), 197-200, 1997.
131. De Salvia, R., Festa, F., Ricordy, R., Perticone, P., and Cozzi, R., Resveratrol affects in a different way primary versus fixed DNA damage induced by H(2)O(2) in mammalian cells in vitro, Toxicol. Lett., 135 (1-2), 4, 2002.
132. Ferry-Dumazet, H., Garnier, O., Mamani-Matsuda, M., Vercauteren, J., Belloc, F., Billiard, C., Dupouy, M., Thiolat, D., Kolb, J.P., Marit, G., Reiffers, J., and Mossalayi, M.D., Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells, Carcinogenesis, 23 (8), 1327-1333, 2002.
133. Nielsen, M., Ruch, R.J., and Vang, O., Resveratrol reverses tumor-promoter-induced inhibition of gapjunctional intercellular communication, Biochem. Biophys. Res. Commun., 275 (3), 804-809, 2000.
134. Schneider, Y., Vincent, F., Duranton, B., Badolo, L., Gosse, F., Bergmann, C., Seiler, N., and Raul, F., Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells, Cancer Lett., 158 (1), 85-91, 2000.
135. Clement, M.V., Hirpara, J.L., Chawdhury, S.H., and Pervaiz, S., Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells, Blood, 92 (3), 996-1002, 1998.
136. Dorrie, J., Gerauer, H., Wachter, Y., and Zunino, S.J., Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells, Cancer Res., 61 (12), 4731-4739, 2001.
137. Ciolino, H.P., Daschner, P.J., and Yeh, G.C., Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor, Cancer Res., 58 (24), 5707-5712, 1998.
138. Revel, A., Raanani, H., Younglai, E., Xu, J., Han, R., Savouret, J.F., and Casper, R.F., Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects sperm from DNA damage and apoptosis caused by benzo(a)pyrene, Reprod. Toxicol., 15 (5), 479-486, 2001.
139. Mutoh, M., Takahashi, M., Fukuda, K., Matsushima-Hibiya, Y., Mutoh, H., Sugimura, T., and Wakabayashi, K., Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure, Carcinogenesis, 21 (5), 959-963, 2000.